HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features-two case reports
Abstract
Introduction: Maturity-Onset Diabetes of the Young (MODY) is a rare monogenic form of diabetes characterized by early onset and autosomal dominant inheritance. MODY-5, caused by HNF1B gene mutations, accounts for <5% of MODY cases and often presents with renal abnormalities and genitourinary malformations.
Case presentation: We describe two patients with HNF1B-related MODY confirmed by heterozygous 17q12 microdeletions. The first case, a 29-year-old woman, presented with diabetes, hypertension, bilateral renal cysts, mild chronic kidney disease (CKD), hypomagnesemia, mild liver enzyme elevations, and a complex Müllerian anomaly requiring surgical correction. She has maintained excellent metabolic control on metformin alone, with no diabetic complications after four years of follow-up. The second case, a 40-year-old man, had a history of diabetes, neonatal left nephrectomy for cystic dysplasia, CKD stage G3bA2, persistent liver enzyme elevation, dorsal pancreatic agenesis, hypomagnesemia, hyperuricemia, mild cognitive impairment, and infertility. He initially achieved good glycemic control with a combination of insulin, metformin, liraglutide, and dapagliflozin, though control subsequently fluctuated. To date, microalbuminuria remains his only diabetes-related complication.
Conclusions: These cases underscore the broad phenotypic spectrum of MODY 5 and highlight the importance of considering HNF1B mutations in young-onset diabetes associated with renal or genitourinary…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.